Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Interest Expense : NT$-7.6 Mil (TTM As of Jun. 2024)

Taiwan Advance Bio-Pharmaceutical Interest Expense Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Interest Expense		Get a 7-Day Free Trial					-10.11	-10.44	-7.43	-6.13	-7.30

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial															-2.79	-3.34	-3.50	-3.80	-3.78

Taiwan Advance Bio-Pharmaceutical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-7.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Advance Bio-Pharmaceutical  (ROCO:4186) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Taiwan Advance Bio-Pharmaceutical's Interest Expense for the six months ended in Jun. 2024 was NT$-3.8 Mil. Its Operating Income for the six months ended in Jun. 2024 was NT$-1.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was NT$70.5 Mil.

Taiwan Advance Bio-Pharmaceutical's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Taiwan Advance Bio-Pharmaceutical Inc interest coverage is 4.45, which is low.

Taiwan Advance Bio-Pharmaceutical Business Description